This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Adel Rafai Far, Ph.D.
Principal Fellow, Chemical and Analytical R&D at Novartis Pharmaceuticals

Profile

Adel Rafai Far, PhD, is a principal fellow, chemical and analytical R&D at Novartis Pharmaceuticals. Prior to joining Novartis, he was employed at The Medicines Company in for 11 years, leading to a position of senior director, drug substance development responsible for the development activities around the inclisiran drug substance, an siRNA designed to reduce LDL cholesterol. Prior to joining The Medicines Company, Adel was director, chemistry, at Targanta Therapeutics, a small company targeting the discovery and development of antibacterial agents. Dr. Rafai Far has a PhD in organic chemistry from the University of Toronto and was a post-doctoral fellow at the Scripps Research Institute.

Agenda Sessions

  • Control of GalNAc siRNA Conjugates

    9:30am